Loading data
NTLANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 67.67 m USD | 57.88 m USD | 36.28 m USD | 52.12 m USD | 33.05 m USD |
| Research and development expense | 388.86 m USD | 466.31 m USD | 435.07 m USD | 419.98 m USD | 229.81 m USD |
| Operating profit | -440.99 m USD | -534.26 m USD | -515.29 m USD | -458.16 m USD | -267.85 m USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -412.69 m USD | -519.02 m USD | -481.19 m USD | -474.19 m USD | -267.89 m USD |
| Basic earnings per share | -3.81 USD/share | -5.25 USD/share | -5.42 USD/share | -6.16 USD/share | -3.78 USD/share |
| Diluted earnings per share | -3.81 USD/share | -5.25 USD/share | -5.42 USD/share | -6.16 USD/share | -3.78 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.